Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
100.87
+0.07 (0.07%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Lantheus Holdings Employees
Lantheus Holdings had 1,193 employees as of December 31, 2025. The number of employees increased by 385 or 47.65% compared to the previous year.
Employees
1,193
Change (1Y)
385
Growth (1Y)
47.65%
Revenue / Employee
$1,304,537
Profits / Employee
$230,767
Market Cap
6.58B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,193 | 385 | 47.65% |
| Dec 31, 2024 | 808 | -26 | -3.12% |
| Dec 31, 2023 | 834 | 136 | 19.48% |
| Dec 31, 2022 | 698 | 86 | 14.05% |
| Dec 31, 2021 | 612 | 17 | 2.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| Indivior Pharmaceuticals | 838 |
| Supernus Pharmaceuticals | 778 |
LNTH News
- 8 days ago - Lantheus downgraded to Neutral from Buy at B. Riley - TheFly
- 9 days ago - Lantheus announces FDA approval of Tauklarify - TheFly
- 11 days ago - US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters
- 11 days ago - Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer's Disease - GlobeNewsWire
- 12 days ago - Lantheus Holdings Proxy statement: Proxy filing - Filings
- 19 days ago - Lantheus Holdings Earnings release: Q2 2026 - Filings
- 19 days ago - Lantheus Holdings Quarterly report: Q2 2026 - Filings
- 19 days ago - Lantheus reports Q2 adjusted EPS $1.55, consensus $1.30 - TheFly